Novo Nordisk’s Rare Disease Breakthrough Fails to Lift Oversold Shares
Novo Nordisk reports positive Phase 3 results for sickle cell drug etavopivat, but shares remain under pressure from…
WHO Foundation and Novo Nordisk expand collaboration to financially support health systems
WHO Foundation and Novo Nordisk expand collaboration to financially support health systems March 15, 2026 | Sunday |…
WHO Foundation and Novo Nordisk expand collaboration to financially support health systems
WHO Foundation and Novo Nordisk expand collaboration to financially support health systems March 15, 2026 | Sunday |…
All Eyes on Copenhagen for Neurodegenerative Disease Data
Denali Therapeutics’ stock surges 32.6% ahead of a pivotal data showcase at the AD/PD 2026 conference, where validation…